Clinical Trials in Houston

Showing 12361-12380 of 15,366 trials

A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours

NCT01065948

The goal of this clinical research study is to learn about a new minimally invasive glucose monitoring device called Fluorescence Affinity Sensor (FAS). In this study, the FAS will be used to determine its effectiveness for glucose monitoring. Researchers want to find out how the device performs at two different body sites (forearm and abdomen) over 4 hours. The safety and comfort level of the device will also be studied.

Diabetes

BioTex, Inc.12 participantsStarted Nov 2009

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy

NCT01286402

This study is designed to gather preliminary effectiveness and safety data on the use of bupropion for smoking cessation in pregnant women attending a community prenatal clinic. This study will provide critical preliminary data in preparation for a larger, Phase III clinical trial.

Smoking Cessation

The University of Texas Health Science Center, Houston11 participantsStarted Apr 2011

Houston, Texas, United States

TERMINATEDPhase 3< 1 mile

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

NCT01190839

REMICADE (infliximab) is a drug used to treat active Crohn's disease and is being tested in an experiment to see if it may be useful in preventing relapse of Crohn's disease after surgical resection. This study will compare the effects (both good and bad) of REMICADE (infliximab) to those of placebo. Placebo looks like the drug being studied but has no active ingredients.

Crohn's Disease

Janssen Biotech, Inc.297 participantsStarted Nov 2010

Birmingham, Alabama, United States • La Jolla, California, United States • Orange, California, United States +139 more locations

A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours

Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy

A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence

Find Trials by Condition in Houston

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome

Combined Treatment for Cocaine-Alcohol Dependence - 1

Trauma Equivalency Study of the CORA® and TEG® 5000 Systems

Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

TearLab Refractive Surgery Dry Eye Study

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)